Sep 15, 2022 / 08:05AM GMT
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research
Good morning, everyone. Welcome to Bank of America's Global Healthcare Conference. I'm Derik De Bruin, the Senior Life Sciences and Diagnostics Tools and biopharma services analyst. It's my pleasure to host Stevanato Group this morning. We have Marco Dal Lago, CFO; and Mauro Stocchi, Chief Business Officer, here today.
Stevanato is a company with a very long history, 70-plus years in the business, but only a newly public company. And with that, I think maybe I am going to do through a couple of slides, just to give some background since it's not a name that's familiar with a lot of investors. And then I'll begin the acquisition of that sense. So gentlemen, thank you for being here, and I'll turn it over to you.
Mauro Stocchi - Stevanato Group S.p.A. - Chief Business Officer
Thank you, Derik, for the introduction. Good morning, everyone. It's really a great pleasure for us to be here with you. And of course, to have the opportunity to talk about Stevanato Group business. So what
Stevanato Group SpA at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Feb 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers